← Evidence map

ReviewBritish journal of cancer2026

Reconsidering the definition of triple-negative breast cancer in the immune checkpoint inhibitor era: an optimal cut-off value for hormone receptor percentage of HER2-negative invasive breast cancer.

Takeo Fujii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 41109918